When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
WVE - Wave Life Sciences falls on setback for Huntington's disease trial
Wave Life Sciences Ltd.
Wave Life Sciences (WVE) has lost more than a quarter after announcing a halt to the clinical development of WVE-120102 and WVE-120101 in Huntington’s disease (“HD”).“mHTT results from PRECISION-HD trials do not support further development of WVE-120102 and WVE-120101,” the company said in a statement.More details to follow.